Lv2
110 积分 2026-03-30 加入
The deconstruction of the psoriasis system based on the theory of state‐target differentiation and treatment
11小时前
求助中
Bimekizumab efficacy and safety through 3 years in patients with moderate-to-severe plaque psoriasis: long-term results from the BE RADIANT phase IIIb trial open-label extension period
2个月前
已完结
Oral Icotrokinra for Plaque Psoriasis in Adults and Adolescents
2个月前
已完结
Bimekizumab efficacy and safety through 3 years in patients with moderate-to-severe plaque psoriasis: long-term results from the BE RADIANT phase IIIb trial open-label extension period
2个月前
已完结
Safety and Efficacy of envudeucitinib, a highly selective, oral allosteric TYK2 inhibitor, in patients with moderate-to-severe plaque psoriasis: Results from the 52-week open-label extension period of the Phase 2 STRIDE study
2个月前
已完结
皖公网安备34019202002308
